Alternative splicing: role in cancer development and progression.
作者信息
Sette Claudio, Ladomery Michael, Ghigna Claudia
机构信息
Dipartimento di Biomedicina e Prevenzione, Università di Roma Tor Vergata, Via Montpellier 1, 00133 Roma, Italy ; Fondazione Santa Lucia, Laboratorio di Neuroembriologia, Via del Fosso di Fiorano 64, 00143 Roma, Italy.
Faculty of Health and Life Sciences, University of the West of England, Coldharbour Lane, Bristol BS16 1QY, UK.
出版信息
Int J Cell Biol. 2013;2013:421606. doi: 10.1155/2013/421606. Epub 2013 Nov 20.
Abstract
摘要
相似文献
1
Alternative splicing: role in cancer development and progression.可变剪接：在癌症发生和发展中的作用
Int J Cell Biol. 2013;2013:421606. doi: 10.1155/2013/421606. Epub 2013 Nov 20.
2
The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression.剪接因子在肿瘤发生和肿瘤进展过程中对可变剪接失调的作用。
Mol Cell Oncol. 2014 Dec 1;2(1):e970955. doi: 10.4161/23723548.2014.970955. eCollection 2015 Jan-Mar.
3
Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools.乳腺癌中的可变剪接与治疗工具的潜在发展
Genes (Basel). 2017 Oct 5;8(10):217. doi: 10.3390/genes8100217.
4
EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression.上皮-间质转化与干性：在发育和癌症进展中由可变剪接调节的灵活过程
Mol Cancer. 2017 Jan 30;16(1):8. doi: 10.1186/s12943-016-0579-2.
5
Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.ESRP1 新兴的多癌症调控作用：通过调控可变剪接控制 EMT。
Curr Cancer Drug Targets. 2020;20(9):654-665. doi: 10.2174/1568009620666200621153831.
6
Many Voices in a Choir: Tumor-Induced Neurogenesis and Neuronal Driven Alternative Splicing Sound Like Suspects in Tumor Growth and Dissemination.合唱中的众多声音：肿瘤诱导的神经发生和神经元驱动的可变剪接似乎是肿瘤生长和扩散的可疑因素。
Cancers (Basel). 2021 Apr 29;13(9):2138. doi: 10.3390/cancers13092138.
7
Alternative splicing-derived intersectin1-L and intersectin1-S exert opposite function in glioma progression.剪接变异体 intersectin1-L 和 intersectin1-S 在胶质瘤进展中发挥相反的作用。
Cell Death Dis. 2019 Jun 3;10(6):431. doi: 10.1038/s41419-019-1668-0.
8
Alternative splicing and tumor progression.可变剪接与肿瘤进展。
Curr Genomics. 2008 Dec;9(8):556-70. doi: 10.2174/138920208786847971.
9
Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy.异常的可变剪接促进肿瘤在靶向治疗和免疫治疗中的抗性。
Transl Oncol. 2021 Jun;14(6):101077. doi: 10.1016/j.tranon.2021.101077. Epub 2021 Mar 26.
10
Prognostic significance of survival-associated alternative splicing events in gastric cancer.生存相关的剪接事件在胃癌中的预后意义。
Aging (Albany NY). 2020 Nov 7;12(21):21923-21941. doi: 10.18632/aging.104013.
引用本文的文献
1
SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer.SRSF5调节BQ323636.1的表达以调节雌激素受体阳性乳腺癌中的他莫昔芬耐药性。
Cancers (Basel). 2023 Apr 13;15(8):2271. doi: 10.3390/cancers15082271.
2
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer.抑制检查点激酶 2 可以逆转 ER 阳性乳腺癌对他莫昔芬的耐药性。
Int J Mol Sci. 2022 Oct 14;23(20):12290. doi: 10.3390/ijms232012290.
3
Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer.靶向核糖体生物合成以对抗雌激素受体阳性乳腺癌中的他莫昔芬耐药性
Cancers (Basel). 2022 Feb 28;14(5):1251. doi: 10.3390/cancers14051251.
4
Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer.靶向白细胞介素-6/信号转导和转录激活因子3信号级联反应以逆转雌激素受体阳性乳腺癌中的他莫昔芬耐药性
Cancers (Basel). 2021 Mar 25;13(7):1511. doi: 10.3390/cancers13071511.
5
RNA-Seq Analysis of Differential Splice Junction Usage and Intron Retentions by DEXSeq.使用DEXSeq对差异剪接连接使用情况和内含子保留进行RNA测序分析
PLoS One. 2015 Sep 1;10(9):e0136653. doi: 10.1371/journal.pone.0136653. eCollection 2015.
6
Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells.PTBP1对PKM可变剪接的调控促进胰腺癌细胞对吉西他滨的耐药性。
Oncogene. 2016 Apr 21;35(16):2031-9. doi: 10.1038/onc.2015.270. Epub 2015 Aug 3.
Zotero 插件